当前位置:首页 - 行情中心 - 派林生物(000403) - 财务分析

派林生物

(000403)

  

流通市值:168.10亿  总市值:169.84亿
流通股本:9.41亿   总股本:9.50亿

派林生物(000403)财务分析

净利润 + 每股收益
Created with Highcharts 9.1.003-3112-3109-3006-30036900.40.81.2
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润0.89亿元,每股收益0.12元。

股东权益 + 未分配利润
Created with Highcharts 9.1.003-3112-3109-3006-30030609019.52122.524
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益800644.15万元,未分配利润236527.24万元。

总资产 + 负债
Created with Highcharts 9.1.003-3112-3109-3006-300408012010.81213.214.4
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产919670.08万元,负债119025.94万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入374,649,641.982,654,684,638.931,890,265,336.271,136,178,207.09
营业总成本276,480,817.31,815,728,401.841,279,639,389.94772,121,600.72
营业利润109,867,387.81880,313,029.04638,752,175.75382,496,851.53
利润总额103,362,342.57852,778,057.65619,546,468.66370,852,765.45
净利润88,939,547.68745,042,150.36542,758,460.07326,975,804.17
其他综合收益-707.317,688.42-5,639.913,460.4
综合收益总额88,938,840.37745,049,838.78542,752,820.16326,979,264.57
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计3,469,649,834.083,578,948,533.753,542,327,499.323,419,669,292.38
非流动资产合计5,727,051,004.775,667,320,831.515,510,888,803.655,417,007,965.65
资产总计9,196,700,838.859,246,269,365.269,053,216,302.978,836,677,258.03
流动负债合计827,866,779.33956,971,752.28871,456,614.84920,173,992.14
非流动负债合计362,392,583.8371,794,977.63356,932,834.4307,449,967.75
负债合计1,190,259,363.131,328,766,729.911,228,389,449.241,227,623,959.89
归属于母公司股东权益合计8,013,739,259.897,924,650,751.557,831,710,847.177,615,971,397.34
股东权益合计8,006,441,475.727,917,502,635.357,824,826,853.737,609,053,298.14
负债和股东权益合计9,196,700,838.859,246,269,365.269,053,216,302.978,836,677,258.03
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计504,109,212.862,548,993,766.251,898,641,784.431,226,861,772.77
经营活动现金流出小计619,948,561.152,227,203,359.981,671,107,587.891,114,003,467.63
经营活动产生的现金流量净额-115,839,348.29321,790,406.27227,534,196.54112,858,305.14
投资活动现金流入小计57,629,268.491,910,661,561.311,004,387,646.63759,489,868.45
投资活动现金流出小计604,346,822.662,246,597,592.071,845,936,861.431,340,894,525.81
投资活动产生的现金流量净额-546,717,554.17-335,936,030.76-841,549,214.8-581,404,657.36
筹资活动现金流入小计120,293,204.46586,078,943.6366,326,135.38226,625,911.31
筹资活动现金流出小计112,173,983.75679,823,658.23426,976,688.04336,884,424.45
筹资活动产生的现金流量净额8,119,220.71-93,744,714.63-60,650,552.66-110,258,513.14
汇率变动对现金及现金等价物的影响-2,924.08-28,116.37-23,319.1513,668.71
现金及现金等价物净增加额-654,440,605.83-107,918,455.49-674,688,890.07-578,791,196.65
期末现金及现金等价物余额665,919,948.781,320,360,554.61753,590,120.03849,487,813.45
最新报告期:2025-05-15
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
海通国际PingPeng,QinZheng,WenxinYu,KehanMeng1.211.391.562025-05-15
中信证券陈竹,王凯旋,韩世通1.201.401.602025-05-08
东方证券伍云飞,赵博宇1.231.421.602025-05-06
万联证券黄婧婧1.221.421.592025-05-06
华源证券刘闯,李强1.231.381.522025-04-30
TOP↑